Equitest 200 is an injectable steroid preparation that contains seven different esters of testosterone. Specifically, each milliliter of oil contains 10 mg of testosterone acetate, 30 mg of testosterone propionate, 20 mg of testosterone phenylpropionate, 20 mg of testosterone caproate, 40 mg of testosterone heptanoate (enanthate), 20 mg of testosterone cyclopentylpropionate (cypionate), and 60 mg of testosterone Decanoate. This blended ester formulation is supposed to result in a rapid increase in testosterone level, followed by a sustained hormone elevation for approximately 3 weeks. The design of this steroid is very similar to Sustanon®, although it contains a slightly different and more extensive blend of testosterones. As a testosterone product, Equitest is capable of producing rapid gains in size and strength. Upon close analysis, Equitest offers no real advantages over Sustanon. Its seven esters all have very similar pharmacokinetic properties to the four esters found in Sustanon, and will display a great deal of similarity in regards to the pattern of testosterone release. Furthermore, blended-ester preparations like these are pharmacologically inferior to testosterone cypionate or enanthate to begin with, as they provide a stronger supraphysiological spike of testosterone the first days of therapy, and an overall greater imbalance between the beginning and later days of each application window. The seven esters are good for marketing, however, as many buyers will identify this product as containing seven different steroids in one.
|Brand name||Equitest 200, Testosterone blend|
Equitest 200 History
Equitest 200 was developed by WDV Pharma, which is a veterinary drug manufacturer based in Myanmar. This company has been operating since the early 1990's, and offers a full line of veterinary drug products (only a few are anabolic steroids). The small size and remoteness of this company in relation to the most active steroid markets would normally have allowed it to stay very low on the radar. However, a couple of their products are unusual enough to catch the attention of dealers and importers looking for marketable items to sell. This includes the seven-testosterone blend of Equitest, as well as their 4-component boldenone injectable called Equilon 100. Equitest 200 remains available today, but is not widely distributed on the global market.
How is Equitest 200 Supplied
Equitest 200 is produced as a veterinary drug product in Myanmar. It contains 200 mg of testosterone ester per milliliter; packaged in 6ml vials.
Structural Characteristics of Equitest 200
Equitest 200 contains a mixture of seven testosterone compounds, which where modified with the addition of carboxylic acid esters (acetic, propionic, propionic phenyl ester, caproic, enanthoic, cyclopentylpropionic, and decanoic acids) at the 17-beta hydroxyl group. Esterified forms of testosterone are less polar than free testosterone, and are absorbed more slowly from the area of injection. Once in the bloodstream, the ester is removed to yield free (active) testosterone. Esterified forms of testosterone are designed to prolong the window of therapeutic effect following administration, allowing for a less frequent injection schedule compared to injections of free (unesterified) steroid. Equitest 200 is designed to provide a rapid peak in testosterone levels (24-48 hours after injection), and maintain elevated concentrations for approximately 21 days.
Equitest 200 Side Effects (Estrogenic)
Testosterone is readily aromatized in the body to estradiol (estrogen). The aromatase (estrogen synthetase) enzyme is responsible for this metabolism of testosterone. Elevated estrogen levels can cause side effects such as increased water retention, body fat gain, and gynecomastia.
Testosterone is considered a moderately estrogenic steroid. An anti-estrogen such as clomiphene citrate or tamoxifen citrate may be necessary to prevent estrogenic side effects. One may alternately use an aromatase inhibitor like Arimidex® (anastrozole), which more efficiently controls estrogen by preventing its synthesis. Aromatase inhibitors can be quite expensive in comparison to anti-estrogens, however, and may also have negative effects on blood lipids.
Estrogenic side effects will occur in a dose-dependant manner, with higher doses (above normal therapeutic levels) of testosterone more likely to require the concurrent use of an anti-estrogen or aromatase inhibitor. Since water retention and loss of muscle definition are common with higher doses of testosterone, this drug is usually considered a poor choice for dieting or cutting phases of training. Its moderate estrogenicity makes it more ideal for bulking phases, where the added water retention will support raw strength and muscle size, and help foster a stronger anabolic environment.
Equitest 200 Side Effects (Androgenic)
Testosterone is the primary male androgen, responsible for maintaining secondary male sexual characteristics. Elevated levels of testosterone are likely to produce androgenic side effects including oily skin, acne, and body/facial hair growth. Men with a genetic predisposition for hair loss (androgenetic alopecia) may notice accelerated male pattern balding. Those concerned about hair loss may find a more comfortable option in nandrolone decanoate, which is a comparably less androgenic steroid. Women are warned of the potential virilizing effects of anabolic/androgenic steroids, especially with a strong androgen such as testosterone. These may include deepening of the voice, menstrual irregularities, changes in skin texture, facial hair growth, and clitoral enlargement.
In androgen-responsive target tissues such as the skin, scalp, and prostate, the high relative androgenicity of testosterone is dependant on its reduction to dihydrotestosterone (DHT). The 5-alpha reductase enzyme is responsible for this metabolism of testosterone. The concurrent use of a 5-alpha reductase inhibitor such as finasteride or dutasteride will interfere with site-specific potentiation of testosterone action, lowering the tendency of testosterone drugs to produce androgenic side effects. It is important to remember that anabolic and androgenic effects are both mediated via the cytosolic androgen receptor. Complete separation of testosterone's anabolic and androgenic properties is not possible, even with total 5-alpha reductase inhibition.
Equitest 200 Side Effects (Hepatotoxicity)
Testosterone does not have hepatotoxic effects; liver toxicity is unlikely. One study examined the potential for hepatotoxicity with high doses of testosterone by administering 400 mg of the hormone per day (2,800 mg per week) to a group of male subjects. The steroid was taken orally so that higher peak concentrations would be reached in hepatic tissues compared to intramuscular injections. The hormone was given daily for 20 days, and produced no significant changes in liver enzyme values including serum albumin, bilirubin, alanine-aminotransferase, and alkaline phosphatases.
Equitest 200 Side Effects (Cardiovascular)
Anabolic/androgenic steroids can have deleterious effects on serum cholesterol. This includes a tendency to reduce HDL (good) cholesterol values and increase LDL (bad) cholesterol values, which may shift the HDL to LDL balance in a direction that favors greater risk of arteriosclerosis. The relative impact of an anabolic/androgenic steroid on serum lipids is dependant on the dose, route of administration (oral vs. injectable), type of steroid (aromatizable or non-aromatizable), and level of resistance to hepatic metabolism. Anabolic/androgenic steroids may also adversely affect blood pressure and triglycerides, reduce endothelial relaxation, and support left ventricular hypertrophy, all potentially increasing the risk of cardiovascular disease and myocardial infarction.
Testosterone tends to have a much less dramatic impact on cardiovascular risk factors than synthetic steroids.This is due in part to its openness to metabolism by the liver, which allows it to have less effect on the hepatic management of cholesterol. The aromatization of testosterone to estradiol also helps to mitigate the negative effects of androgens on serum lipids. In one study, 280 mg per week of testosterone ester (enanthate) had a slight but not statistically significant effect on HDL cholesterol after 12 weeks, but when taken with an aromatase inhibitor a strong (25%) decrease was seen. Studies using 300 mg of testosterone ester (enanthate) per week for 20 weeks without an aromatase inhibitor demonstrated only a 13% decrease in HDL cholesterol, while at 600 mg the reduction reached 21 %. The negative impact of aromatase inhibition should be taken into consideration before such drug is added to testosterone therapy.
Due to the positive influence of estrogen on serum lipids, tamoxifen citrate or clomiphene citrate are preferred to aromatase inhibitors for those concerned with cardiovascular health, as they offer a partial estrogenic effect in the liver.This allows them to potentially improve lipid profiles and offset some of the negative effects of androgens. With doses of 600 mg or less per week, the impact on lipid profile tends to be noticeable but not dramatic, making an anti-estrogen (for cardioprotective purposes) perhaps unnecessary. Doses of 600 mg or less per week have also failed to produce statistically significant changes in LDL/VLDL cholesterol, triglycerides, apolipoprotein B/C-lll, C-reactive protein, and insulin sensitivity, all indicating a relatively weak impact on cardiovascular risk factors. When used in moderate doses, injectable testosterone esters are usually considered to be the safest of all anabolic/androgenic steroids.
To help reduce cardiovascular strain it is advised to maintain an active cardiovascular exercise program and minimize the intake of saturated fats, cholesterol, and simple carbohydrates at all times during active AAS administration. Supplementing with fish oils (4 grams per day) and a natural cholesterol/antioxidant formula such as Lipid Stabil or a product with comparable ingredients is also recommended.
Equitest 200 Side Effects (Testosterone Suppression)
All anabolic/androgenic steroids when taken in doses sufficient to promote muscle gain are expected to suppress endogenous testosterone production. Testosterone is the primary male androgen, and offers strong negative feedback on endogenous testosterone production. Testosterone-based drugs will, likewise, have a strong effect on the hypothalamic regulation of natural steroid hormones. Without the intervention of testosterone-stimulating substances, testosterone levels should return to normal within 1-4 months of drug secession. Note that prolonged hypogonadotrophic hypogonadism can develop secondary to steroid abuse, necessitating medical intervention.
Equitest 200 Administration (Men)
For bodybuilding purposes, this drug is usually injected on a weekly basis, at a dosage of 200-600 mg. Cycles are generally between 6 and 12 weeks in length.This level is sufficient to provide excellent gains in muscle size and strength.Testosterone drugs are ultimately very versatile, and can be combined with many other anabolic/androgenic steroids depending on the desired effect.
Equitest 200 Administration (Women)
Equitest 200 is not recommended for women for physique- or performance-enhancing purposes due to its strong androgenic nature, tendency to produce virilizing side effects, and slow-acting characteristics (making blood levels difficult to control).
Equitest 200 Availability
Equitest 200 is circulated on the black market, but not in high volume.
Wlliam Llewellyn (2017) - Anabolics